BibTeX
CSL-JSON
MLA
Harvard
Transient Mutism Related to Capecitabine-Induced Acute Toxic Leukoencephalopathy
release_qjs3g3oj2fecrmpqlstmfdrrmu
by
Hyung Ho Kim,
Hyunji Kim,
Sumin Kim,
Soo-Hyun Kim,
Geon Ha Kim
Published
in Journal of the Korean Neurological Association
by Korean Neurological Association.
2022 Volume 40, p172-175
Abstract
Capecitabine, a precursor of 5-fluorouracil (5-FU), is a well-tolerated and safe chemotherapy that has been used to treat breast, pancreatic, and colorectal cancers. Albeit rare, both 5-FU and capecitbine have been reported to be associated with acute central nervous system toxicity, including cerebellar dysfunction, posterior reversible encephalopathy syndrome, and transient leukoencephalopathies. Here we present a case of 32-year-old female, demonstrating transient mutism related to capecitabine induced acute toxic leukoencephalopathy.
In application/xml+jats format
Archived Files and Locations
application/pdf
1.7 MB
file_lbwg53t2pbhqrfxeibe5hjncgy
|
www.jkna.org (publisher) web.archive.org (webarchive) |
Read Archived PDF
Preserved and Accessible
Journal Metadata
Open Access Publication
Not in DOAJ
In ISSN ROAD
Not in Keepers Registry
ISSN-L:
Open Access Publication
Not in DOAJ
In ISSN ROAD
Not in Keepers Registry
ISSN-L:
1225-7044
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links
oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar